BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, December 17, 2025
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Dec. 16, 2025

Dec. 16, 2025
Clinical updates, including data readouts and publications: Argenx, Ascletis, Aviceda, Gilead, Immunome, Innocare, Kyverna, Orca, Palvella, Radiopharm.
Read More

In the clinic for Dec. 16, 2025

Dec. 16, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cleerly, Hologic, Hummingbird Diagnostics, Natera, Nucleix.
Read More

In the clinic for Dec. 16, 2025

Dec. 16, 2025
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Ascentage, Ascletis, Biomx, Deciphera, Innocare, Innovent, Kazia, Lyell, Vivacta Bio.
Read More

In the clinic for Dec. 15, 2025

Dec. 15, 2025
Clinical updates, including data readouts and publications: AB Science, Anixa, Arcus, Ausperbio, Avenzo, Beyondspring, Cullgen, Innovent, Innoviva, Relay, Tenaya.
Read More

In the clinic for Dec. 15, 2025

Dec. 15, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Radiopharm Theranostics.
Read More

In the clinic for Dec. 12, 2025

Dec. 12, 2025
Clinical updates, including data readouts and publications: Beyondspring, Carrick, Corbus, Elicio, Genoscience, GRI, Immatics, Immunewalk, Novabridge, Okyo, Rhythm, Valneva.
Read More

In the clinic for Dec. 12, 2025

Dec. 12, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Exact Sciences, Roivios.
Read More

In the clinic for Dec. 11, 2025

Dec. 11, 2025
Clinical updates, including data readouts and publications: Barinthus, Briacell, Cellenkos, Idorsia, Igyxos, Innocare, Journey, Karolinksa, Kazia, Medicenna, Mendus, Roche.
Read More

In the clinic for Dec. 11, 2025

Dec. 11, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Baxter, Caris Life Sciences, Personalis, Volitionrx.
Read More

In the clinic for Dec. 10, 2025

Dec. 10, 2025
Clinical updates, including data readouts and publications: Abcuro, Akeso, Aleta, Ascentage, Assembly, Beone, Biontech, BMS, Enterprise, Halia, Harmony, Incyte, Innovent, Johnson & Johnson, Kallyope, Kamada, Lundbeck, Lyell, Maat, March, Miltenyi, Oncoc4, ONL, Orca Bio, Realta, Structure, Targed, Terns, UCB.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 310 311 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 16, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Kim Woo-youn, CEO and cofounder, Hits

    Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery

    BioWorld Science
    Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing